TBXA2Ralpha: A Key Regulator of TGF-beta Signaling (G6915)

Target Name: TBXA2R

NCBI ID: G6915

TBXA2R

TBXA2Ralpha: A Key Regulator of TGF-beta Signaling

TBXA2Ralpha, also known as TXA2-Ralpha, is a protein that is expressed in various tissues throughout the body. It is a key regulator of the Transforming Growth Factor beta (TGF-beta) signaling pathway, which is involved in many cellular processes, including cell growth, differentiation, and inflammation.

The TGF-beta signaling pathway is a well-established framework for many diseases, including cancer, neurodegenerative diseases, and developmental disorders. It is a highly conserved pathway that is involved in the regulation of many cellular processes, including cell proliferation, Differentiation, angiogenesis , and inflammation. The TGF-beta signaling pathway is activated by various factors, including growth factors, which include proteins such as TGF-beta1, TGF-beta2, and TGF-beta3.

TBXA2Ralpha is a protein that is expressed in various tissues throughout the body and is involved in the regulation of the TGF-beta signaling pathway. It is a key regulator of the TGF-beta signaling pathway, and it plays a critical role in the regulation of cellular processes, including cell growth, differentiation, and inflammation.

One of the key functions of TBXA2Ralpha is its ability to regulate the activity of the TGF-beta signaling pathway. This is accomplished through the regulation of the activity of the TGF-beta receptor, which is a protein that is involved in the TGF-beta signaling pathway. The TGF-beta receptor is a transmembrane protein that is involved in the regulation of cellular processes, including cell growth, differentiation, and inflammation.

TBXA2Ralpha is able to regulate the activity of the TGF-beta receptor by interacting with it on the surface of the TGF-beta receptor. This interaction between TBXA2Ralpha and the TGF-beta receptor is critical for the regulation of the TGF-beta signaling pathway.

In addition to its role in regulating the TGF-beta signaling pathway, TBXA2Ralpha is also involved in the regulation of many other cellular processes. For example, it is involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs. It is also involved in the regulation of cell migration, which is the process by which cells move from one location to another in the body.

TBXA2Ralpha is also involved in the regulation of inflammation. It is a key regulator of the production of pro-inflammatory cytokines, which are molecules that play a critical role in the regulation of inflammation.

In conclusion, TBXA2Ralpha is a protein that is involved in the regulation of many cellular processes, including the TGF-beta signaling pathway and the regulation of cell adhesion, migration, and inflammation. Its function as a drug target or biomarker makes it an attractive target for the development of new therapies for a variety of diseases.

Protein Name: Thromboxane A2 Receptor

Functions: Receptor for thromboxane A2 (TXA2), a potent stimulator of platelet aggregation. The activity of this receptor is mediated by a G-protein that activates a phosphatidylinositol-calcium second messenger system. In the kidney, the binding of TXA2 to glomerular TP receptors causes intense vasoconstriction. Activates phospholipase C

The "TBXA2R Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TBXA2R comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets